INVO Fertility, Inc. (IVF) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by INVO Fertility, Inc. on October 10, 2025, covering an event that occurred on October 6, 2025. The Company is incorporated in Nevada and its common stock trades on The Nasdaq Stock Market LLC under the symbol "IVF".
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, or margin data. The specific financial activity reported is a capital raise of $200,000 in cash received from an institutional investor.
Material Changes
- Unregistered Sale of Equity: On October 6, 2025, an existing holder of Series C-2 Convertible Preferred Stock exercised an Additional Investment Right.
- Transaction Details: The investor acquired 200 shares of C-2 Preferred Stock with an aggregate stated value of $200,000 for $200,000 in cash.
- Conversion Price Adjustment: As a result of this exercise, the conversion price on the C-2 Preferred Stock adjusted to $0.6643 per share.
- Regulatory Status: The securities were sold without registration under the Securities Act, relying on exemptions under Section 4(a)(2) and/or Rule 506.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, or specific risk factors beyond the standard disclosure regarding the unregistered nature of the securities sale. The transaction was executed pursuant to a Securities Purchase Agreement dated January 3, 2024, and a Joinder Agreement dated October 11, 2024.
Investor Verification Checklist
- Verify the updated conversion price of $0.6643 per share for Series C-2 Convertible Preferred Stock.
- Confirm the total outstanding shares of C-2 Preferred Stock following the issuance of the 200 new shares.
- Review the July 1, 2025 Form 8-K (Item 1.01) referenced in this filing for additional context on the Securities Purchase Agreement.
- Assess the impact of the $200,000 cash inflow on the Company's current liquidity position.